BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 31, 2002
View Archived Issues
Amylin Seeks $92M Publicly To Fund AC2993 Phase IIIs
Amylin Pharmaceuticals Inc. started the second of three Phase III trials on AC2993, a compound designed to treat people with Type II diabetes by improving glucose control. (BioWorld Today)
Read More
Signature Continues Acquisitions, Buys PDL’s Small-Molecule Unit
Signature BioScience Inc. is moving toward drug discovery and fueling the trek with acquisitions. (BioWorld Today)
Read More
Scar Tissue In Injured Spinal Cord Acts As Barrier Preventing Normal Regeneration, Functional Recovery
Read More
IntraBiotics Netting $13.9M From Private Deal For Iseganan Studies
Read More
Other News To Note
Read More
Appointments And Advancements
Read More